About the Company
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for adults and children with rare and difficult-to-treat cancers. The company is headquartered in Houston, Texas, United States.
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & Apparatus
Employees
19
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on PLUS THERAPEUTICS, INC.
Plus Therapeutics Presents Positive ReSPECT-LM Clinical Trial Results of REYOBIQ™ in Leptomeningeal Metastases
REYOBIQ produced a clinical benefit rate of over 75% in 3 clinically relevant outcome measures RNA sequencing and circulating ...
Plus Therapeutics Reports Stockholders’ Equity in Excess of $2.5 million in Compliance with Nasdaq Equity Requirements
Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a clinical-stage pharmaceutical company developing targeted ...
Plus Therapeutics Reports Strong Q2 2025 Results
Plus Therapeutics ( ($PSTV) ) has released its Q2 earnings. Here is a breakdown of the information Plus Therapeutics presented to its investors.
Plus Therapeutics Reports Second Quarter Financial Results and Recent Business Highlights
Net income for second quarter of 2025 was $5.2 million, or $0.02 per share, compared to a net loss of $2.9 million, or $ ...
Plus Therapeutics, Inc. to Host Business Update Conference ... - Nasdaq
Plus Therapeutics, Inc. announced that it will provide a business update on June 26, 2025, before the market opens. The management team will host a conference call and webcast at 9:00 a.m. ET to ...
Plus Therapeutics, Inc. Reports Q1 2025 Financial Results and ... - Nasdaq
Plus Therapeutics, Inc. has reported financial results for the first quarter ending March 31, 2025, highlighting significant progress in its clinical trials for REYOBIQ™, a targeted ...
Plus Therapeutics, Inc. (PSTV) Q3 2023 Earnings Call Transcript
Plus Therapeutics, Inc. (NASDAQ:PSTV) Q3 2023 Earnings Conference Call October 31, 2023 5:00 PM ETCorporate ParticipantsMarc Hedrick - President and Chief ...
Plus Therapeutics, Inc. Receives Notification of ... - Morningstar
Plus Therapeutics, Inc. 737-255-7194 ir@plustherapeutics.com The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties.
Why Plus Therapeutics, Inc. (PSTV) Soared on Thursday
Plus Therapeutics, Inc. (NASDAQ:PSTV) soared by 311.43 percent on Thursday to finish at $1.44 apiece as investors gobbled up shares in the company following the Food and Drug Administration (FDA ...
Plus Therapeutics, Inc. (PSTV) Q4 2023 Earnings Call Transcript
Plus Therapeutics, Inc. (NASDAQ:PSTV) Q4 2023 Earnings Conference Call March 5, 2024 5:00 PM ETCompany ParticipantsMarc Hedrick - President and CEOAndrew ...
Plus Therapeutics, Inc. (NASDAQ:PSTV) Q4 2023 Earnings Call Transcript
Plus Therapeutics, Inc. (NASDAQ: PSTV) Q4 2023 Earnings Call Transcript March 5, 2024 Plus Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.7, expectations were $-0.78.
Similar Companies
Loading the latest forecasts...